SELLAS Life Sciences Group (SLS) Short Interest Ratio & Short Volume $1.06 +0.08 (+7.86%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends SELLAS Life Sciences Group Short Interest DataSELLAS Life Sciences Group (SLS) has a short interest of 7.97 million shares. This marks a 6.84% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.0, indicating that it would take 7.0 days of the average trading volume of 1.17 million shares to cover all short positions.Current Short Interest7,970,000 sharesPrevious Short Interest7,460,000 sharesChange Vs. Previous Month+6.84%Dollar Volume Sold Short$8.29 millionShort Interest Ratio7.0 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares70,380,000 sharesPercentage of Shares Shorted11.32%Today's Trading Volume3,289,812 sharesAverage Trading Volume1,170,623 sharesToday's Volume Vs. Average281% Short Selling SELLAS Life Sciences Group? Sign up to receive the latest short interest report for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSLS Short Interest Over TimeSLS Days to Cover Over TimeSLS Percentage of Float Shorted Over Time SELLAS Life Sciences Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20247,970,000 shares $8.29 million +6.8%N/A7 $1.04 12/15/20247,460,000 shares $6.51 million -17.6%N/A7.6 $0.87 11/30/20249,050,000 shares $10.23 million +3.2%N/A11.2 $1.13 11/15/20248,770,000 shares $11.58 million +1.9%N/A14.3 $1.32 10/31/20248,610,000 shares $10.16 million +41.6%N/A16.1 $1.18 10/15/20246,080,000 shares $7.30 million -25.7%N/A10.2 $1.20 9/30/20248,180,000 shares $10.23 million +0.3%N/A13 $1.25 9/15/20248,160,000 shares $10.77 million -0.7%N/A12.4 $1.32 8/31/20248,220,000 shares $10.60 million +6.5%N/A9.2 $1.29 8/15/20247,720,000 shares $9.80 million -27.5%N/A8.4 $1.27 Get the Latest News and Ratings for SLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE daily newsletter. 7/31/202410,650,000 shares $12.35 million +9.6%N/A11 $1.16 7/15/20249,720,000 shares $10.59 million +9.7%N/A8.3 $1.09 6/30/20248,860,000 shares $10.54 million +17.4%N/A7.2 $1.19 6/15/20247,550,000 shares $11.33 million -1.3%N/A5.2 $1.50 5/31/20247,650,000 shares $10.79 million +5.5%N/A5.3 $1.41 5/15/20247,250,000 shares $10.66 million +3.7%N/A4.7 $1.47 4/30/20246,990,000 shares $8.67 million +23.3%N/A4.6 $1.24 4/15/20245,670,000 shares $7.54 million +7.6%N/A4 $1.33 3/31/20245,270,000 shares $5.32 million +1.7%N/A3.6 $1.01 3/15/20245,180,000 shares $5.70 million +14.9%N/A3.7 $1.10 2/29/20244,510,000 shares $4.56 million +15.9%N/A4.2 $1.01 2/15/20243,890,000 shares $2.74 million +24.7%N/A3.7 $0.70 1/31/20243,120,000 shares $2.00 million -19.6%N/A3.1 $0.64 1/15/20243,880,000 shares $2.07 million -18.0%N/A4.3 $0.53 12/31/20234,730,000 shares $5.01 million +1.5%N/A4.9 $1.06 12/15/20234,660,000 shares $5.36 million +1.1%N/A6.3 $1.15 11/30/20234,610,000 shares $4.79 million +0.7%N/A7.3 $1.04 11/15/20234,580,000 shares $4.44 million +50.2%N/A8.7 $0.97 10/31/20233,050,000 shares $2.96 million +49.5%N/A6.6 $0.97 10/15/20232,040,000 shares $2.65 million +87.2%N/A6.5 $1.30 9/30/20231,090,000 shares $1.79 million +6.9%N/A7.7 $1.64 9/15/20231,020,000 shares $1.64 million -9.7%N/A8.1 $1.61 8/31/20231,130,000 shares $1.66 million No ChangeN/A8.9 $1.47 8/15/20231,130,000 shares $1.68 million -4.2%N/A8.7 $1.49 7/31/20231,180,000 shares $1.94 million +2.6%N/A8.2 $1.64 7/15/20231,150,000 shares $1.97 million -0.9%N/A7.4 $1.71 6/30/20231,160,000 shares $1.82 million +3.6%N/A6.8 $1.57 6/15/20231,120,000 shares $1.86 million -5.9%N/A5.4 $1.66 5/31/20231,190,000 shares $2.04 million -4.8%N/A4.8 $1.72 5/15/20231,250,000 shares $2.05 million +4.2%N/A2.7 $1.64Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know. 4/30/20231,200,000 shares $1.69 million +1.7%N/A2.6 $1.41 4/15/20231,180,000 shares $1.89 million +7.3%N/A2.6 $1.60 3/31/20231,100,000 shares $1.57 million -9.8%N/A2.4 $1.43 3/15/20231,220,000 shares $1.68 million -5.4%N/A3 $1.38 2/28/20231,290,000 shares $2.18 million +7.5%N/A3.5 $1.69 2/15/20231,200,000 shares $3.79 million +2.6%N/A4.1 $3.16 1/31/20231,170,000 shares $3.88 million -2.5%N/A4.5 $3.32 1/15/20231,200,000 shares $3.41 million -3.2%N/A3.6 $2.84 12/30/20221,240,000 shares $2.93 million +0.8%N/A3.3 $2.36 12/15/20221,230,000 shares $2.85 million +1.7%N/A3.4 $2.32 11/30/20221,210,000 shares $2.89 million +5.2%N/A3.3 $2.39 11/15/20221,150,000 shares $2.58 million +15.4%N/A3.3 $2.24 10/31/2022996,800 shares $4.67 million +21.3%N/A3.8 $4.68 10/15/2022822,000 shares $1.57 million -0.9%N/A4.5 $1.91 9/30/2022829,600 shares $1.68 million -0.7%N/A8.3 $2.02 9/15/2022835,100 shares $2.51 million +0.1%N/A7.8 $3.00 8/31/2022834,400 shares $2.55 million -6.1%N/A7.1 $3.06 8/15/2022888,700 shares $2.88 million +5.9%N/A6.6 $3.24 7/31/2022838,900 shares $2.15 million -2.3%N/A5.4 $2.56 7/15/2022858,900 shares $2.16 million -4.1%N/A5.3 $2.52 6/30/2022895,600 shares $2.00 million -0.3%N/A4.7 $2.23 6/15/2022897,800 shares $2.22 million +6.0%N/A3 $2.47 5/31/2022847,000 shares $2.58 million -10.1%N/A3 $3.05 5/15/2022942,500 shares $2.51 million +8.6%N/A3.4 $2.66 4/30/2022867,800 shares $2.36 million -5.2%N/A3.5 $2.72 4/15/2022915,500 shares $3.22 million -8.5%N/A3.5 $3.52 3/31/20221,000,000 shares $6.68 million No ChangeN/A4 $6.68 3/15/20221,000,000 shares $5.38 million +1.2%N/A7.3 $5.38 2/28/2022988,000 shares $6.03 million -1.1%N/A7 $6.10 2/15/2022999,200 shares $6.48 million +1.3%N/A7.1 $6.49 1/31/2022986,700 shares $5.27 million +15.4%N/A5.8 $5.34 1/15/2022854,700 shares $4.73 million +10.0%N/A5.6 $5.53 12/31/2021776,800 shares $4.30 million -2.4%N/A5.1 $5.53 12/15/2021796,100 shares $5.10 million +9.6%N/A5.1 $6.40 11/30/2021726,200 shares $4.89 million +11.8%N/A4.4 $6.74 11/15/2021649,600 shares $4.85 million -3.5%N/A3.7 $7.47 10/29/2021672,900 shares $5.85 million -22.1%N/A3.7 $8.69 10/15/2021863,200 shares $7.62 million +4.1%N/A4.3 $8.83 9/30/2021829,200 shares $7.60 million +7.2%N/A3.6 $9.16 9/15/2021773,700 shares $7.78 million -14.2%N/A1.7 $10.05 8/31/2021901,200 shares $8.37 million -23.6%N/A1.8 $9.29 8/13/20211,180,000 shares $11.88 million No ChangeN/A2 $10.07 7/30/20211,180,000 shares $10.10 million +4.4%N/A2 $8.56 7/15/20211,130,000 shares $9.75 million +28.9%N/A1.9 $8.63 6/30/2021876,900 shares $9.73 million +27.3%N/A1.5 $11.10 6/15/2021688,900 shares $7.89 million -10.9%N/A1.4 $11.45 5/28/2021773,400 shares $9.25 million -15.2%N/A1.5 $11.96 5/14/2021911,600 shares $0.00 +1.2%6.1%1.7 $0.00 4/30/2021901,100 shares $7.22 million -4.2%6.1%1.4 $8.01 4/15/2021940,100 shares $7.76 million +20.2%6.3%0.5 $8.25Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know. 3/31/2021782,300 shares $6.27 million -8.2%5.3%0.4 $8.02 3/15/2021852,100 shares $8.74 million +5.9%6.1%0.4 $10.26 2/26/2021805,000 shares $6.74 million -16.2%5.8%0.1 $8.37 2/12/2021960,400 shares $8.85 million +5.2%6.9%0.2 $9.21 1/29/2021912,700 shares $5.02 million +43.4%8.1%0.2 $5.50 1/15/2021636,300 shares $3.85 million -15.4%5.6%0.2 $6.05 12/31/2020752,000 shares $4.39 million -40.3%6.7%0.2 $5.84 12/15/20201,260,000 shares $8.43 million +127.5%11.3%0.3 $6.69 11/30/2020553,900 shares $2.06 million +51.1%6.2%1.3 $3.72 11/15/2020366,600 shares $964,158.00 -11.1%4.1%2.3 $2.63 10/30/2020412,200 shares $1.08 million -0.1%4.6%2.9 $2.63 10/15/2020412,500 shares $1.10 million -1.6%4.6%2.1 $2.66 SLS Short Interest - Frequently Asked Questions What is SELLAS Life Sciences Group's current short interest? Short interest is the volume of SELLAS Life Sciences Group shares that have been sold short but have not yet been covered or closed out. As of December 31st, investors have sold 7,970,000 shares of SLS short. Learn More on SELLAS Life Sciences Group's current short interest. What is a good short interest ratio for SELLAS Life Sciences Group? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLS shares currently have a short interest ratio of 7.0. Learn More on SELLAS Life Sciences Group's short interest ratio. Is SELLAS Life Sciences Group's short interest increasing or decreasing? SELLAS Life Sciences Group saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 7,970,000 shares, an increase of 6.8% from the previous total of 7,460,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does SELLAS Life Sciences Group's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to SELLAS Life Sciences Group: C4 Therapeutics, Inc. (12.18%), Candel Therapeutics, Inc. (11.06%), Benitec Biopharma Inc. (0.27%), Foghorn Therapeutics Inc. (2.77%), UroGen Pharma Ltd. (24.86%), Lifecore Biomedical, Inc. (7.61%), Heron Therapeutics, Inc. (20.19%), Atai Life Sciences (9.17%), Eledon Pharmaceuticals, Inc. (2.09%), COMPASS Pathways plc (5.69%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short SELLAS Life Sciences Group stock? Short selling SLS is an investing strategy that aims to generate trading profit from SELLAS Life Sciences Group as its price is falling. SLS shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against SELLAS Life Sciences Group? A short squeeze for SELLAS Life Sciences Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SLS, which in turn drives the price of the stock up even further. How often is SELLAS Life Sciences Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLS, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies CCCC Short Interest Data CADL Short Interest Data BNTC Short Interest Data FHTX Short Interest Data URGN Short Interest Data LFCR Short Interest Data HRTX Short Interest Data ATAI Short Interest Data ELDN Short Interest Data CMPS Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLS) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SELLAS Life Sciences Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SELLAS Life Sciences Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
